Work

Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.

Year: 1988

Type: article

Source: PubMed

Authors: A Eisenthal, R B Cameron, I Uppenkamp, S A Rosenberg

Institution: National Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1797331953

FWCI: 1.869

Cites: 28

Cited by: 29

Related to: 10